Cyclo Therapeutics (CYTH)
(Delayed Data from NSDQ)
$0.66 USD
-0.02 (-3.06%)
Updated Sep 10, 2024 03:59 PM ET
After-Market: $0.66 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -0.15 |
EPS Last Quarter | -0.21 |
Last EPS Surprise | -50.00% |
ABR | 2.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.66 |
Next Year | -0.66 |
EPS (TTM) | -0.88 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.12M | 0.12M | 0.57M | 0.51M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.12M | 0.12M | 0.57M | 0.51M |
Low Estimate | 0.12M | 0.12M | 0.57M | 0.51M |
Year ago Sales | 0.50M | 0.31M | 1.07M | 0.57M |
Year over Year Growth Est. | -76.00% | -61.29% | -46.98% | -10.53% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.15 | -0.17 | -0.66 | -0.66 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | -0.17 | -0.66 | -0.66 |
High Estimate | -0.15 | -0.17 | -0.66 | -0.66 |
Low Estimate | -0.15 | -0.17 | -0.66 | -0.66 |
Year ago EPS | -0.29 | -0.23 | -1.23 | -0.66 |
Year over Year Growth Est. | 48.28% | 26.09% | 46.34% | 0.00% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.15 | -0.17 | -0.66 | -0.66 |
7 Days Ago | -0.15 | -0.17 | -0.66 | -0.66 |
30 Days Ago | -0.15 | -0.18 | -0.62 | -0.49 |
60 Days Ago | -0.15 | -0.18 | -0.62 | -0.49 |
90 Days Ago | -0.15 | -0.18 | -0.62 | -0.49 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.15 | -0.17 | -0.66 | -0.66 |
Zacks Consensus Estimate | -0.15 | -0.17 | -0.66 | -0.66 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.21 | -0.15 | -0.23 | -0.29 | NA |
Estimate | -0.14 | -0.20 | NA | NA | NA |
Difference | -0.07 | 0.05 | NA | NA | -0.01 |
Surprise | -50.00% | 25.00% | NA | NA | -12.50% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more